Dr. Gwendolyn Grant, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1010 Three Springs Blvd Ste 275, Durango, CO 81301 Phone: 970-764-3740 Fax: 970-764-3643 |
News Archive
Immunotherapy with the anti-PD-1 antibody pembrolizumab (Keytruda) was effective in one out of four patients with recurrent or metastatic head and neck cancer, according to results presented at the 2015 meeting of the American Society for Clinical Oncology.
A new paper in the British Medical Journal by Jan Blustein, M.D., Ph.D., of New York University's Wagner School and a professor of Medicine and Population Health at NYU School of Medicine and Jianmeng Liu, M.D., Ph.D., of Peking University examines the evidence as to whether newborns delivered by Cesarean section are more likely to develop chronic diseases later in life.
Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI. A key focus of this cooperation will be sub-Saharan Africa, which the World Health Organization estimates to account for 90 percent of global HIV infections in children.
AVAC's annual report, titled "AVAC Report 2011: The End?," "is intended as a vision and a challenge to the field, and a first step in holding all of us - civil society, researchers, governments, and funders - accountable for progress" toward ending AIDS, according to the AVAC website (12/22).
The natural form of Prialt – a new drug for severe pain approved this week by the U.S. Food and Drug Administration – was discovered at the University of Utah in 1979 by an incoming freshman studying toxins produced by cone snails.
› Verified 4 days ago